Waters Corporation $WAT Shares Acquired by Kestra Advisory Services LLC

Kestra Advisory Services LLC lifted its holdings in Waters Corporation (NYSE:WAT – Free Report) by 41.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,947 shares of the medical instruments supplier’s stock after purchasing an additional 1,161 shares during the quarter. Kestra Advisory Services LLC’s holdings in Waters were worth $1,734,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Pilgrim Global Advisors LLC bought a new stake in Waters in the 2nd quarter worth approximately $466,131,171,000. BlackRock Inc. bought a new position in shares of Waters during the 2nd quarter valued at $3,182,191,000. State Street Corp lifted its holdings in shares of Waters by 0.5% during the 2nd quarter. State Street Corp now owns 4,382,008 shares of the medical instruments supplier’s stock valued at $1,643,428,000 after buying an additional 19,998 shares during the period. Jupiter Topco LLC purchased a new position in shares of Waters in the 2nd quarter worth $623,921,000. Finally, Janus Henderson Group PLC boosted its stake in shares of Waters by 27.0% in the 1st quarter. Janus Henderson Group PLC now owns 1,638,772 shares of the medical instruments supplier’s stock worth $488,028,000 after buying an additional 348,379 shares during the last quarter. 94.01% of the stock is owned by institutional investors.

Waters Trading Down 0.9%

Waters stock opened at $449.28 on Wednesday. Waters Corporation has a 12-month low of $282.77 and a 12-month high of $483.33. The firm has a market capitalization of $44.16 billion, a price-to-earnings ratio of 192.82, a P/E/G ratio of 2.58 and a beta of 1.16. The firm has a 50 day moving average of $442.24 and a 200 day moving average of $374.83. The company has a current ratio of 1.89, a quick ratio of 1.28 and a debt-to-equity ratio of 0.29.

Waters (NYSE:WAT – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.00 by $0.10. The business had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.75 billion. Waters had a net margin of 1.75% and a return on equity of 9.91%. The company’s revenue for the quarter was up 120.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.40 earnings per share. As a group, research analysts predict that Waters Corporation will post 14.65 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on WAT shares. Evercore upped their price target on shares of Waters from $410.00 to $480.00 in a research report on Wednesday, October 7th. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a report on Saturday. Barclays raised their price objective on shares of Waters from $500.00 to $530.00 and gave the stock an “overweight” rating in a report on Wednesday, November 4th. Stifel Nicolaus set a $470.00 target price on shares of Waters in a research report on Wednesday, November 4th. Finally, HSBC upped their target price on shares of Waters from $450.00 to $455.00 and gave the company a “buy” rating in a report on Tuesday, September 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $475.48.

View Our Latest Research Report on Waters

Waters Company Profile

(Free Report)

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Recommended Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.